Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2025-12-31 @ 5:24 PM
Study NCT ID:
NCT05169905
Status:
COMPLETED
Last Update Posted:
2023-04-07
First Post:
2021-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-10
First Submit QC Date:
None
Study First Post Date:
2021-12-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-24
Results First Submit QC Date:
None
Results First Post Date:
2023-04-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-06
Last Update Post Date:
2023-04-07
Last Update Post Date Type:
ACTUAL